[Echo-Doppler duplex combined with intracavernous injection of prostaglandin E1 in the diagnosis of impotence]
- PMID: 1586215
[Echo-Doppler duplex combined with intracavernous injection of prostaglandin E1 in the diagnosis of impotence]
Abstract
Sixty-two patients that had consulted for impotence were evaluated by intracavernal injection of prostaglandin E1 and duplex echo-Doppler. The internal diameter and the mean flow of the cavernosal arteries were determined by echo-Doppler in the flaccid state. Thereafter 20 micrograms of PGE 1 was injected intracavernously and the erectile response was evaluated clinically after 5 to 15 minutes. Another Doppler evaluation was performed during tumescence to study the changes of the internal diameter and the mean flow increase of the cavernal arteries. Twenty-nine patients (46.7%) achieved normal erection after intracavernal PGE 1 and the Doppler study was normal in all but 2 patients (3.2%). The remaining 33 patients (53.1%) failed to achieve normal erection following intracavernal injection of PGE 1. The Doppler study, however, was normal in 7 of these patients (11.2%), which indicates venous leak to be the underlying cause of impotence. There were minor complications (19.3%) presented a small hematoma at the site of injection and 12.9% referred moderate pain at the time of injection) and no patient has a sustained erection for more than 3 hours. The hemodynamic mechanisms and the current concepts relative to the neurologic aspects of erection are discussed. We believe duplex echo-Doppler combined with intracavernal PGE 1 to be a very reliable method in the diagnosis of impotence of a vascular origin. It can distinguish those patients that cannot achieve erection following intracavernal PGE 1 with a normal arterial tree whose impotence can be ascribed to venous leak.
Similar articles
-
[Intracavernous auto-injection of prostaglandin E1 for diagnosis and treatment of erectile dysfunction].Harefuah. 1994 Apr 1;126(7):369-73, 426. Harefuah. 1994. PMID: 8200581 Hebrew.
-
Sexual impotence caused by vascular disease: diagnosis with duplex sonography.AJR Am J Roentgenol. 1989 Dec;153(6):1149-53. doi: 10.2214/ajr.153.6.1149. AJR Am J Roentgenol. 1989. PMID: 2683673
-
Relation between intracavernosal dose of prostaglandin Pge 1 and mean duration of erection in men with different underlying causes of erectile dysfunction.Croat Med J. 2007 Feb;48(1):76-80. Croat Med J. 2007. PMID: 17309142 Free PMC article.
-
Evidence based assessment of erectile dysfunction.Int J Impot Res. 1998 May;10 Suppl 2:S64-73; discussion S77-9. Int J Impot Res. 1998. PMID: 9647964 Review.
-
[Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].Actas Urol Esp. 1992 Mar;16(3):208-16. Actas Urol Esp. 1992. PMID: 1621545 Review. Spanish.
Cited by
-
Intracavernous prostaglandin E1 in erectile dysfunction.Clin Investig. 1994 Jan;72(2):139-49. doi: 10.1007/BF00184593. Clin Investig. 1994. PMID: 8186662 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical